Parkinson ' s disease . Clinical and [ 18 F ] dopa PET findings in early
暂无分享,去创建一个
[1] R A Robb,et al. A software system for interactive and quantitative visualization of multidimensional biomedical images. , 1991, Australasian physical & engineering sciences in medicine.
[2] Wade K. Smith,et al. Midbrain dopaminergic cell loss in parkinson's disease: Computer visualization , 1989, Annals of neurology.
[3] C D Marsden,et al. The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET. , 1990, Brain : a journal of neurology.
[4] S. Goto,et al. Subdivisional involvement of nigrostriatal loop in idiopathic parkinson's disease and striatonigral degeneration , 1989, Annals of neurology.
[5] W. Gibb,et al. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.
[6] A. E. Harding,et al. Parkinson's disease in twins studied with 18F‐dopa and positron emission tomography , 1992, Neurology.
[7] J. Langston,et al. Does a long preclinical period occur in Parkinson's disease? , 1991, Neurology.
[8] G. Sawle,et al. Separating Parkinson's disease from normality. Discriminant function analysis of fluorodopa F 18 positron emission tomography data. , 1994, Archives of neurology.
[9] K. Jellinger,et al. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. , 1973, Journal of the neurological sciences.
[10] C S Patlak,et al. Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[11] V. Dhawan,et al. Input functions for 6-[fluorine-18]fluorodopa quantitation in parkinsonism: comparative studies and clinical correlations. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[12] A. Lees,et al. Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.
[13] M. Hoehn,et al. Parkinsonism , 1967, Neurology.
[14] C. Patlak,et al. Striatal 18F-DOPA Uptake: Absence of an Aging Effect , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[15] Richard S. J. Frackowiak,et al. Striatal function in normal aging: Implications for Parkinson's disease , 1990, Annals of neurology.
[16] D J Brooks,et al. Detection of preclinical Parkinson's disease with PET , 1991, Neurology.
[17] D B Calne,et al. Correlation of striatal fluorodopa uptake in the MPTP Monkey with dopaminergic indices , 1993, Annals of neurology.
[18] H. Kimura,et al. Human positron emission tomographic [18F]Fluorodopa studies correlate with dopamine cell counts and levels , 1993, Annals of neurology.
[19] K. Jellinger,et al. The Neuropathologic Basis of Different Clinical Subgroups of Parkinson's Disease , 1991, Journal of neuropathology and experimental neurology.
[20] R. Schwab,et al. Progression of unilateral tremor and rigidity in Parkinson's disease , 1970, Neurology.